Q-RETIX AI
AI-Powered Pharmaceutical Intelligence for Research, Drug Discovery, and Clinical Analysis.
Platform Solutions
Comprehensive AI tools designed for every stage of pharmaceutical research and development.
Smart Drug Discovery
AI-driven molecular screening and target identification to accelerate candidate selection.
AI Data Processing
Real-time processing of multi-omics datasets, clinical records, and research literature.
Clinical Research Intelligence
Automated trial monitoring, patient stratification, and endpoint analysis.
Laboratory Automation
Smart workflow orchestration for high-throughput screening and assay management.
Predictive Healthcare
Machine learning models for outcome prediction, risk stratification, and biomarker discovery.
Research Analytics
Comprehensive dashboards and reports for research progress, compliance, and funding metrics.
Research Timeline
From discovery to delivery — track every milestone with precision and transparency. Our structured pipeline ensures rigorous validation at every stage.
Discovery
Preclinical
Clinical Trials
Regulatory
Manufacturing
Commercial
Latest Insights & Research
Stay updated with breakthroughs in AI-powered healthcare, research, product updates, and medical innovation.
Generative AI for Molecule Design
Exploring how generative models like diffusion models and transformers are revolutionizing de novo drug design.
Optimizing Clinical Trials with Machine Learning
Machine learning approaches to patient stratification, adaptive trial design, and real-world evidence integration.
Precision Medicine Breakthroughs Powered by AI
From genomic biomarkers to personalized dosing algorithms, AI is enabling truly individualized therapies.
Pharma Supply Chain Resilience with AI
Predictive analytics and digital twins are helping pharmaceutical companies build resilient supply chains.
Trusted by Researchers, Doctors & Healthcare Innovators
Discover why healthcare professionals choose Q-RETIX AI.
Dr. Sarah Chen
Chief Medical Officer • St. Jude Medical Center
"Q-RETIX AI has transformed our diagnostic pipeline. We've seen a 40% reduction in false negatives and our radiologists now trust AI-assisted screening as a first-line tool."
Dr. James Wilson
Head of Research • Novartis Institute
"The drug discovery acceleration is remarkable. What used to take our team 18 months for lead compound identification now happens in under 8 weeks with Q-RETIX's molecular analysis."
Dr. Maria Rodriguez
Clinical Trial Director • Johns Hopkins Medicine
"Patient stratification used to be our biggest bottleneck. Q-RETIX's AI models now identify optimal cohorts with 94% accuracy, saving us millions in trial costs."
Prof. Alan Park
Director of AI Research • Stanford Medicine
"As an academic researcher, I need tools that are transparent and reproducible. Q-RETIX delivers explainable AI with full audit trails — essential for regulatory submissions."
Dr. Sarah Chen
Chief Medical Officer • St. Jude Medical Center
"Q-RETIX AI has transformed our diagnostic pipeline. We've seen a 40% reduction in false negatives and our radiologists now trust AI-assisted screening as a first-line tool."
Dr. James Wilson
Head of Research • Novartis Institute
"The drug discovery acceleration is remarkable. What used to take our team 18 months for lead compound identification now happens in under 8 weeks with Q-RETIX's molecular analysis."
Dr. Maria Rodriguez
Clinical Trial Director • Johns Hopkins Medicine
"Patient stratification used to be our biggest bottleneck. Q-RETIX's AI models now identify optimal cohorts with 94% accuracy, saving us millions in trial costs."
Prof. Alan Park
Director of AI Research • Stanford Medicine
"As an academic researcher, I need tools that are transparent and reproducible. Q-RETIX delivers explainable AI with full audit trails — essential for regulatory submissions."
Dr. Emily Foster
Medical AI Specialist • Mayo Clinic
"The integration with our existing PACS system was seamless. Within 2 weeks, our pathologists were using Q-RETIX for automated tissue analysis daily."
Dr. Robert Kim
Pharmaceutical Consultant • McKinsey Health
"I've recommended Q-RETIX to three Fortune 500 pharma clients. The regulatory document generation alone saves their compliance teams 200+ hours per submission."
Dr. Lisa Thompson
Precision Medicine Lead • Memorial Sloan Kettering
"Personalized oncology is data-intensive. Q-RETIX's multi-omics integration lets us build comprehensive patient profiles that guide targeted therapy selection."
Dr. Michael Chang
Healthcare Startup Founder • MedVision AI
"Building our own AI models would have taken 2 years and $5M. Q-RETIX gave us production-ready medical vision APIs in 6 weeks. Game changer for our startup."
Dr. Emily Foster
Medical AI Specialist • Mayo Clinic
"The integration with our existing PACS system was seamless. Within 2 weeks, our pathologists were using Q-RETIX for automated tissue analysis daily."
Dr. Robert Kim
Pharmaceutical Consultant • McKinsey Health
"I've recommended Q-RETIX to three Fortune 500 pharma clients. The regulatory document generation alone saves their compliance teams 200+ hours per submission."
Dr. Lisa Thompson
Precision Medicine Lead • Memorial Sloan Kettering
"Personalized oncology is data-intensive. Q-RETIX's multi-omics integration lets us build comprehensive patient profiles that guide targeted therapy selection."
Dr. Michael Chang
Healthcare Startup Founder • MedVision AI
"Building our own AI models would have taken 2 years and $5M. Q-RETIX gave us production-ready medical vision APIs in 6 weeks. Game changer for our startup."
Join The Q-RETIX AI Community
Get early access to pharmaceutical intelligence tools and connect with researchers, scientists, and healthcare innovators worldwide.
Why join?
Connect with pharmaceutical researchers, scientists, healthcare professionals, and AI innovators shaping the future of drug discovery and clinical research.
Newsletter Perks
- Research Articles & Whitepapers
- AI & Machine Learning Insights
- Industry & Regulatory Reports
- Clinical Research Updates
- Drug Discovery Breakthroughs